Relating to information provided by health care providers and hospitals to certain patients regarding pharmaceutical manufacturer patient assistance programs for insulin.
Bill status
passed
3 of 5 stages cleared
Introduction
Mar 2021
Committee Review
May 2021
House Passage
May 2021
Senate Passage
Governor
Introduced Mar 24, 2021
Last action May 12, 2021
Floor votes
How they voted
This bill passed the House. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
27
Key actions
9
Committee
10
May 12, 2021
Committee
Referred to Health & Human Services
upper
May 12, 2021
Introduced
Read first time
upper
May 12, 2021
Introduced
Received from the House
upper
May 11, 2021
Lower · Passed
Passed
lower
May 11, 2021
Lower · Passed
Passed to engrossment
lower
May 1, 2021
Lower · Passed
Committee report distributed
lower
Apr 30, 2021
Lower · Passed
Comte report filed with Committee Coordinator
lower
Apr 27, 2021
Lower · Passed
Reported favorably as substituted
lower
Apr 27, 2021
Committee
Recommended to be sent to Local & Consent
lower
Apr 27, 2021
Lower · Passed
Committee substitute considered in committee
lower
Apr 20, 2021
Lower · Passed
Left pending in committee
lower
Apr 20, 2021
Lower · Passed
Testimony taken/registration(s) recorded in committee
lower
Apr 20, 2021
Lower · Passed
Committee substitute considered in committee
lower
Mar 24, 2021
Committee
Referred to Insurance
lower
Mar 24, 2021
Introduced
Read first time
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Tom Oliverson
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 3922
Scope: TX
Hi! I can help you understand HB 3922. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline